Bellevue Group »

4d Molecular Therapeutics In shares owned by Bellevue Group

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Bellevue Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $330k 16k 20.99
2024-03-31 $500k 16k 31.86
2023-06-30 $813k 45k 18.07